Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
NUS logo

Nu Skin Enterprises Inc (NUS)

Upturn stock ratingUpturn stock rating
Nu Skin Enterprises Inc
$7.69
Delayed price
Profit since last BUY2.26%
Consider higher Upturn Star rating
upturn advisory
BUY since 14 days
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

12/05/2024: NUS (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Analysis of Past Performance​

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: Consider higher Upturn Star rating
Historic Profit: -24.45%
Upturn Advisory Performance Upturn Advisory Performance3
Avg. Invested days: 22
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 12/05/2024
Type: Stock
Today’s Advisory: Consider higher Upturn Star rating
Historic Profit: -24.45%
Avg. Invested days: 22
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 12/05/2024
Upturn Advisory Performance Upturn Advisory Performance3

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 387.25M USD
Price to earnings Ratio -
1Y Target Price 8.25
Dividends yield (FY) 3.20%
Basic EPS (TTM) -2.09
Volume (30-day avg) 815874
Beta 1.13
52 Weeks Range 5.90 - 20.26
Updated Date 12/10/2024
Company Size Small-Cap Stock
Market Capitalization 387.25M USD
Price to earnings Ratio -
1Y Target Price 8.25
Dividends yield (FY) 3.20%
Basic EPS (TTM) -2.09
Volume (30-day avg) 815874
Beta 1.13
52 Weeks Range 5.90 - 20.26
Updated Date 12/10/2024

Earnings Date

Report Date -
When -
Estimate -
Actual -
Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -5.81%
Operating Margin (TTM) 4.24%

Management Effectiveness

Return on Assets (TTM) 5.55%
Return on Equity (TTM) -13.5%

Revenue by Products

Revenue by Products - Current and Previous Year

Revenue by Geography

Revenue by Geography - Current and Previous Year

Valuation

Trailing PE -
Forward PE -
Enterprise Value 636825650
Price to Sales(TTM) 0.22
Enterprise Value to Revenue 0.36
Enterprise Value to EBITDA 81.05
Shares Outstanding 49711000
Shares Floating 48667586
Percent Insiders 2.29
Percent Institutions 81.19
Trailing PE -
Forward PE -
Enterprise Value 636825650
Price to Sales(TTM) 0.22
Enterprise Value to Revenue 0.36
Enterprise Value to EBITDA 81.05
Shares Outstanding 49711000
Shares Floating 48667586
Percent Insiders 2.29
Percent Institutions 81.19

Analyst Ratings

Rating 3
Target Price 27.75
Buy -
Strong Buy -
Hold 3
Sell -
Strong Sell -
Rating 3
Target Price 27.75
Buy -
Strong Buy -
Hold 3
Sell -
Strong Sell -

AI Summarization

Nu Skin Enterprises Inc.: A Comprehensive Overview

Company Profile:

History and Background:

Nu Skin Enterprises Inc. (NYSE: NUS) was founded in 1984 by Blake Roney and Sandie Tillotson as a multi-level marketing (MLM) company specializing in personal care and nutritional products. Through its MLM network of independent distributors, Nu Skin sells its products in over 50 markets across the globe.

Core Business Areas:

  • Personal Care: Includes anti-aging skincare, hair care, cosmetics, and fragrances.
  • Nutritional Products: Offers vitamins, supplements, protein shakes, and weight management solutions.
  • Technology Products: Includes the ageLOC Me device and the LUMISpa skin care device.
  • Other Products: Include home care and air purification systems.

Leadership Team and Corporate Structure:

  • Ryan Napierski: President and Chief Executive Officer
  • Ritch Wood: Chief Operating Officer
  • Joseph Yorio: Chief Financial Officer
  • Doran Barnes: Chief Legal Officer and General Counsel
  • Marc Goldstein: Chief Scientific Officer
  • Steven Lund: Executive Vice President, Chief Technology Officer
  • Belinda Wang: Executive Vice President, Chief People Officer
  • Deon Garrett: Executive Vice President, Chief Global Sales Officer
  • Joseph Hong: Executive Vice President, Chief Greater China Regional Officer

Top Products and Market Share:

Top Products:

  • ageLOC Me: A personalized skincare system with interchangeable cartridges tailored to individual needs.
  • ageLOC LumiSpa: A facial cleansing and treatment device claimed to improve skin texture and clarity.
  • Tru Face Line Corrector: A serum designed to reduce the appearance of fine lines and wrinkles.
  • G3: A weight management system combining nutritional supplements, workout programs, and coaching support.
  • LifePak: A multivitamin and mineral supplement claimed to provide complete nutritional support.

Market Share:

Nu Skin holds a small market share in the global beauty and wellness industry, estimated to be around 0.5%. In the US market, its share is slightly higher, around 1%. The company faces stiff competition from larger multinational players like L'Oréal, Unilever, Procter & Gamble, and Amway.

Total Addressable Market:

The global beauty and wellness market is valued at over $500 billion and is expected to grow steadily in the coming years, driven by increasing consumer demand for self-care products and rising disposable incomes.

Financial Performance:

Recent Financial Statements:

  • Revenue: $2.3 billion (2022)
  • Net Income: $156.4 million (2022)
  • Profit Margin: 6.7% (2022)
  • Earnings per Share (EPS): $3.38 (2022)

Year-over-Year Performance:

Nu Skin's revenue has been relatively flat over the past five years. Net income and EPS have shown some volatility, but the overall trend is positive.

Cash Flow and Balance Sheet:

Nu Skin has a healthy cash flow and a strong balance sheet with low debt levels.

Dividends and Shareholder Returns:

Dividend History:

Nu Skin has a history of paying dividends, although the payout ratio is relatively low. The current annual dividend yield is around 1.5%.

Shareholder Returns:

Total shareholder returns over the past five years have been around 25%, outperforming the S&P 500 index.

Growth Trajectory:

Historical Growth:

Nu Skin's growth has been slow and inconsistent over the past five years.

Future Growth Projections:

The company's future growth prospects are uncertain. The aging population and rising demand for self-care products could provide growth opportunities. However, intense competition and regulatory challenges pose risks to the company's growth potential.

Market Dynamics:

Industry Overview:

The beauty and wellness industry is highly fragmented and competitive. Major industry trends include the increasing popularity of natural and organic products, personalization, and the use of technology in skincare and wellness.

Nu Skin's Position:

Nu Skin competes in the premium segment of the beauty and wellness market, targeting affluent and health-conscious consumers. The company faces competitive pressure from both large multinational companies and smaller niche players.

Key Competitors:

  • L'Oréal (OR.PA): Global beauty giant with a diverse portfolio of brands.
  • Unilever (ULVR.L): Another multinational consumer goods company with a strong presence in the beauty and personal care market.
  • Procter & Gamble (PG): Well-known for its household brands, P&G also offers a range of beauty and personal care products.
  • Amway (AMWAY): Another prominent MLM company operating in the beauty and wellness industry.

Potential Challenges and Opportunities:

Challenges:

  • Int

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Nu Skin Enterprises Inc

Exchange NYSE Headquaters Provo, UT, United States
IPO Launch date 1996-11-21 President, CEO & Director Mr. Ryan S. Napierski
Sector Consumer Defensive Website https://www.nuskin.com
Industry Household & Personal Products Full time employees 3700
Headquaters Provo, UT, United States
President, CEO & Director Mr. Ryan S. Napierski
Website https://www.nuskin.com
Website https://www.nuskin.com
Full time employees 3700

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​